24/7 Market News Snapshot 26 December, 2024 – Hoth Therapeutics, Inc. Common Stock (NASDAQ:HOTH)

December 26, 2024

DENVER, Colo., 26 December, 2024 (247marketnews.com) – (NASDAQ:HOTH) are discussed in this article.
Hoth Therapeutics, Inc. (HOTH), a pioneering biopharmaceutical firm, is currently witnessing a significant uptrend in pre-market trading, with its stock price reaching $0.880, signifying an impressive increase of approximately 11.82% from the previous market close of $0.787. This bullish movement is accompanied by notable trading activity, with 5.66 million shares exchanged, reflecting heightened investor interest and potential momentum. Analysts suggest that sustaining this upward trajectory could establish a support level around $0.80, while challenging resistance at $0.90 could provide further opportunities for engagement.

In addition to its market performance, Hoth is making strides in the biopharmaceutical arena through a strategic partnership with the U.S. Department of Veterans Affairs (VA). The company has secured an exclusive patent license agreement to a portfolio co-developed with Emory University, focusing on “Glial Cell Line-Derived Neurotrophic Factor, Obesity, and Obesity-Related Diseases and Conditions.” This collaboration represents a crucial development in Hoth’s mission to combat obesity and related health issues, an area of significant public health concern.

Robb Knie, Chief Executive Officer of Hoth Therapeutics, emphasized the importance of this agreement, stating, “The collaboration with the VA and Emory University is a pivotal step in our ongoing efforts to create science-driven solutions for obesity and related conditions.” Hoth is also set to enhance its intellectual property coverage by pursuing provisional patent protection for its leading therapeutic, HT-001, aimed at expanding treatment options for various cancers.

Through these initiatives, Hoth Therapeutics remains dedicated to transforming innovative scientific discoveries into market-ready healthcare solutions, keen on improving patient outcomes and addressing critical medical needs on a global scale.

Related news for (HOTH)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.